Search research articles
Contact Us
Filters
Showing results (321-330 of 347) with videos related to
Page
of 35
Sort By:
Annals of the Rheumatic Diseases
|
May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
Sara Monti, Alessandra Milanesi, Catherine Klersy, et al.
Autoimmunity Reviews
|
November 9, 2018
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
Roberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
Scientific Reports
|
October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus
Alessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Autoimmunity Reviews
|
December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Journal of Autoimmunity
|
October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
Mariele Gatto, Francesca Saccon, Laura Andreoli, et al.
RMD Open
|
May 7, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
Zohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, et al.
Journal of Autoimmunity
|
January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors
Luca Quartuccio, Milena Bond, Miriam Isola, et al.
Frontiers in Immunology
|
July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
Jurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
The Lancet. Rheumatology
|
February 8, 2026
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study
Chiara Tani, Chiara Cardelli, Luca Moroni, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 347) with videos related to
Sort By:
Page
of 35
Annals of the Rheumatic Diseases
|
May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
Sara Monti, Alessandra Milanesi, Catherine Klersy, et al.
Autoimmunity Reviews
|
November 9, 2018
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
Roberto Giacomelli, Antonella Afeltra, Alessia Alunno, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
Scientific Reports
|
October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus
Alessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Autoimmunity Reviews
|
December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Journal of Autoimmunity
|
October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
Mariele Gatto, Francesca Saccon, Laura Andreoli, et al.
RMD Open
|
May 7, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis
Zohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, et al.
Journal of Autoimmunity
|
January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors
Luca Quartuccio, Milena Bond, Miriam Isola, et al.
Frontiers in Immunology
|
July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry
Jurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
The Lancet. Rheumatology
|
February 8, 2026
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study
Chiara Tani, Chiara Cardelli, Luca Moroni, et al.
Page
of 35